The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins

[1]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[2]  A. Kengne,et al.  VEGF, the underlying factor for metabolic syndrome; fact or fiction? , 2017, Diabetes & metabolic syndrome.

[3]  C. Gieger,et al.  Association of Atopic Dermatitis with Cardiovascular Risk Factors and Diseases. , 2017, The Journal of investigative dermatology.

[4]  M. Mohammadi,et al.  Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion. , 2017, International journal of cardiology.

[5]  An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease. , 2017, The Journal of investigative dermatology.

[6]  J. Lee,et al.  Association Between Metabolic Syndrome and Atopic Dermatitis in Korean Adults. , 2017, Acta dermato-venereologica.

[7]  Mayte Suárez-Fariñas,et al.  Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling , 2016, The Journal of allergy and clinical immunology.

[8]  D. Cassimos,et al.  Assessment of IgE-mediated food allergies in children with atopic dermatitis. , 2017, Allergologia et immunopathologia.

[9]  D. Messerer,et al.  Allergies - A T cells perspective in the era beyond the TH1/TH2 paradigm. , 2017, Clinical immunology.

[10]  J. Silverberg,et al.  Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder. , 2017, The Journal of investigative dermatology.

[11]  J. Knight,et al.  XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits , 2016, Genome Medicine.

[12]  A. Paller,et al.  Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. , 2016, The Journal of allergy and clinical immunology.

[13]  I. Peshkova,et al.  The role of cytokines in the development of atherosclerosis , 2016, Biochemistry (Moscow).

[14]  U. Olsson‐Strömberg,et al.  Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. , 2016, Leukemia research.

[15]  J. Pankow,et al.  Hepatocyte Growth Factor Is Positively Associated With Risk of Stroke: The MESA (Multi-Ethnic Study of Atherosclerosis) , 2016, Stroke.

[16]  J. Silverberg,et al.  Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. , 2016, The New England journal of medicine.

[17]  S. Feldman,et al.  Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study , 2016, Dermatology and Therapy.

[18]  I. Gonçalves,et al.  Endarterectomy patients with elevated levels of circulating IL-16 have fewer cardiovascular events during follow-up. , 2016, Cytokine.

[19]  Jaw-Wen Chen,et al.  Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? , 2016, Cardiovascular Diabetology.

[20]  C. Akdis,et al.  Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. , 2016, The Journal of allergy and clinical immunology.

[21]  Cong-Lin Liu,et al.  Interaction between allergic asthma and atherosclerosis. , 2016, Translational research : the journal of laboratory and clinical medicine.

[22]  G. Canonica,et al.  A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma , 2016, International Archives of Allergy and Immunology.

[23]  E. Galkina,et al.  Smooth Muscle Cell–Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[24]  A. Qureshi,et al.  Atopic dermatitis is not independently associated with nonfatal myocardial infarction or stroke among US women , 2016, Allergy.

[25]  J. Silverberg,et al.  Associations of Physical Activity and Sedentary Behavior with Atopic Disease in United States Children. , 2016, The Journal of pediatrics.

[26]  L. Skov,et al.  Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. , 2016, The Journal of allergy and clinical immunology.

[27]  Henning Hermjakob,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic acids research.

[28]  C. Bodemer,et al.  Kaposiform Haemangioendothelioma-spectrum Lesions with Kasabach-Merritt Phenomenon: Retrospective Analysis and Long-term Outcome. , 2016, Acta dermato-venereologica.

[29]  C. Gieger,et al.  Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. , 2016, The Journal of allergy and clinical immunology.

[30]  K. Yim,et al.  Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms , 2016, Rheumatology International.

[31]  H. Bøtker,et al.  Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis. , 2015, The American journal of medicine.

[32]  A. Kimball,et al.  Psoriasis and Cardiovascular Disease. , 2015, The Medical clinics of North America.

[33]  C. Workman,et al.  Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways , 2015, BMC Medical Genomics.

[34]  J. Silverberg.  Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population‐based studies , 2015, Allergy.

[35]  C. Flohr,et al.  Biomarkers for atopic dermatitis: a systematic review and meta-analysis , 2015, Current opinion in allergy and clinical immunology.

[36]  A. Paller,et al.  Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. , 2015, The Journal of allergy and clinical immunology.

[37]  I. Gonçalves,et al.  Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events , 2015, Stroke.

[38]  N. Ward,et al.  Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation , 2015, The Journal of Immunology.

[39]  E. Ingelsson,et al.  Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis. , 2015, Atherosclerosis.

[40]  M. Suárez-Fariñas,et al.  Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis. , 2015, The Journal of allergy and clinical immunology.

[41]  M. Suárez-Fariñas,et al.  Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. , 2015, The Journal of allergy and clinical immunology.

[42]  Mayte Suárez-Fariñas,et al.  RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. , 2015, The Journal of allergy and clinical immunology.

[43]  E. Guttman‐Yassky,et al.  Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics , 2015, Journal of clinical medicine.

[44]  J. Silverberg,et al.  Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. , 2015, Journal of the American Academy of Dermatology.

[45]  J. Silverberg,et al.  Eczema and cardiovascular risk factors in 2 US adult population studies. , 2015, The Journal of allergy and clinical immunology.

[46]  J. Silverberg,et al.  Central obesity and high blood pressure in pediatric patients with atopic dermatitis. , 2015, JAMA dermatology.

[47]  C. Ryan,et al.  Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. , 2015, Dermatologic clinics.

[48]  B. Strober,et al.  Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities. , 2014, The American journal of medicine.

[49]  I. Bechmann,et al.  Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[50]  M. Namba,et al.  Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus. , 2014, World journal of diabetes.

[51]  Yung-Ting Chang,et al.  Autoimmune disease comorbidities in patients with atopic dermatitis: a nationwide case–control study in Taiwan , 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[52]  Yu-Dong Cai,et al.  Gene Ontology and KEGG Enrichment Analyses of Genes Related to Age-Related Macular Degeneration , 2014, BioMed research international.

[53]  Z. Rancic,et al.  Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability. , 2014, Nuclear medicine and biology.

[54]  J. Silverberg,et al.  Association Between Obesity and Eczema Prevalence, Severity and Poorer Health in US Adolescents , 2014, Dermatitis : contact, atopic, occupational, drug.

[55]  C. Steyers,et al.  Endothelial Dysfunction in Chronic Inflammatory Diseases , 2014, International journal of molecular sciences.

[56]  M. Suárez-Fariñas,et al.  Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. , 2014, The Journal of allergy and clinical immunology.

[57]  J. Silverberg.  Persistence of childhood eczema into adulthood. , 2014, JAMA dermatology.

[58]  D. Margolis,et al.  Persistence of mild to moderate atopic dermatitis. , 2014, JAMA dermatology.

[59]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[60]  Tzeng-Ji Chen,et al.  Atopic dermatitis and risk of ischemic stroke: A nationwide population-based study , 2014, Annals of medicine.

[61]  D. Duprez,et al.  Cardiovascular risk and psoriasis: beyond the traditional risk factors. , 2014, The American journal of medicine.

[62]  L. Arends,et al.  Markers of systemic inflammation in psoriasis: a systematic review and meta‐analysis , 2013, The British journal of dermatology.

[63]  N. Novak,et al.  Immunology of atopic eczema: overcoming the Th1/Th2 paradigm , 2013, Allergy.

[64]  Laura K Ferris,et al.  Anti-cytokine therapy in the treatment of psoriasis. , 2013, Cytokine.

[65]  J. Gudjonsson,et al.  Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation , 2013, The Journal of Immunology.

[66]  Jean-Fred Fontaine,et al.  CXCL5 limits macrophage foam cell formation in atherosclerosis. , 2013, The Journal of clinical investigation.

[67]  M. Suárez-Fariñas,et al.  Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.

[68]  G. Newton,et al.  IL-17 and TNF-α Sustain Neutrophil Recruitment during Inflammation through Synergistic Effects on Endothelial Activation , 2012, The Journal of Immunology.

[69]  R. Fölster-Holst,et al.  IL‐31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis , 2012, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[70]  T. Honda,et al.  Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis. , 2011, European journal of dermatology : EJD.

[71]  Lincoln Stein,et al.  Reactome pathway analysis to enrich biological discovery in proteomics data sets , 2011, Proteomics.

[72]  Steffen Jung,et al.  CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. , 2011, The Journal of clinical investigation.

[73]  Martin Lundberg,et al.  Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood , 2011, Nucleic acids research.

[74]  J. Krueger,et al.  Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. , 2011, The Journal of allergy and clinical immunology.

[75]  M. D. de Bruin‐Weller,et al.  Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. , 2011, Journal of the American Academy of Dermatology.

[76]  B. Mahon,et al.  IL-17A Induces CCL28, Supporting the Chemotaxis of IgE-Secreting B Cells , 2011, International Archives of Allergy and Immunology.

[77]  K. Varady,et al.  Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans. , 2011, Nutrition reviews.

[78]  H. Cheng,et al.  Correlations of Serum Interleukin-16, Total IgE, Eosinophil Cationic Protein and Total Eosinophil Counts with Disease Activity in Children with Atopic Dermatitis , 2011, International journal of immunopathology and pharmacology.

[79]  古賀 千律子.  Possible pathogenic role of Th17 cells for atopic dermatitis , 2011 .

[80]  Wu Kg,et al.  Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. , 2011 .

[81]  H. Uchi,et al.  Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis. , 2011, Journal of dermatological science.

[82]  Luis Puig,et al.  Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. , 2010, The Journal of investigative dermatology.

[83]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[84]  D. Böckler,et al.  Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice1 , 2009, The Journal of Immunology.

[85]  R. Khalil,et al.  Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.

[86]  D. Diaconu,et al.  Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis. , 2009, The American journal of pathology.

[87]  Kenneth H. Buetow,et al.  PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..

[88]  A. Sharpe,et al.  T-Cell Costimulation and Coinhibition in Atherosclerosis , 2008, Circulation research.

[89]  J. Carucci,et al.  Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.

[90]  Lieping Chen,et al.  CD137 Is Expressed in Human Atherosclerosis and Promotes Development of Plaque Inflammation in Hypercholesterolemic Mice , 2008, Circulation.

[91]  Khusru Asadullah,et al.  Immunopathogenesis of psoriasis , 2007, Experimental dermatology.

[92]  Jon M Hanifin,et al.  A Population‐Based Survey of Eczema Prevalence in the United States , 2007, Dermatitis : contact, atopic, occupational, drug.

[93]  F. Mach,et al.  The specific role of chemokines in atherosclerosis , 2007, Thrombosis and Haemostasis.

[94]  W. Ouyang,et al.  Role of cytokine therapy in the treatment of psoriasis , 2007 .

[95]  Léon Personnaz,et al.  Enrichment or depletion of a GO category within a class of genes: which test? , 2007, Bioinform..

[96]  M. Jiang,et al.  IL-20 Is Expressed in Atherosclerosis Plaques and Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[97]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[98]  W. Owczarek,et al.  Serum thymus and activation‐regulated chemokine, macrophage‐derived chemokine and eotaxin as markers of severity of atopic dermatitis , 2005, Allergy.

[99]  K. Ahn,et al.  LIGHT is involved in the pathogenesis of rheumatoid arthritis by inducing the expression of pro‐inflammatory cytokines and MMP‐9 in macrophages , 2005, Immunology.

[100]  S. Targan,et al.  LIGHT Is Constitutively Expressed on T and NK Cells in the Human Gut and Can Be Induced by CD2-Mediated Signaling1 , 2005, The Journal of Immunology.

[101]  T. Imaizumi,et al.  Regulation of CX3CL1/fractalkine expression in endothelial cells. , 2004, Journal of atherosclerosis and thrombosis.

[102]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[103]  V. Koppaka,et al.  anti* , 2002, Annals of Internal Medicine.

[104]  Yoon Lee,et al.  Tumor Necrosis Factor Receptor Superfamily 14 Is Involved in Atherogenesis by Inducing Proinflammatory Cytokines and Matrix Metalloproteinases , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[105]  M. Lebwohl,et al.  Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. , 2001, The Journal of investigative dermatology.

[106]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.